<DOC>
	<DOCNO>NCT00107939</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness tolerability investigational drug treatment manic episode bipolar disorder . The investigational drug give additional therapy one five follow medication : risperidone , olanzapine , quetiapine , ziprasidone , aripiprazole . These medication already FDA ( Food Drug Administration ) -approved treatment mania .</brief_summary>
	<brief_title>Study Licarbazepine Treatment Manic Episodes Bipolar Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<criteria>Diagnosis bipolar disorder ( type I ) manic mixed episode ( include patient with/without psychotic feature with/without history rapid cycling ) In need psychiatric treatment Cooperation willingness complete aspect study Current diagnosis bipolar I disorder History schizophrenia schizoaffective disorder Drug dependence within 1 month prior study start test positive urine drug test Suicide attempt within 1 month prior study start immediate risk harm self others Any form psychotherapy within 1 month prior study start</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>bipolar disorder</keyword>
	<keyword>manic episode</keyword>
	<keyword>treatment</keyword>
	<keyword>licarbazepine</keyword>
</DOC>